1.Clinical Analysis of Anesthesia for Cheiloplasty and Palatoplasty in Children under 10 Years Old Age .
Sook Ja KIM ; Byung Mu KIM ; Ji Hyoung KIM ; Dong Ki LEE
Korean Journal of Anesthesiology 1981;14(2):192-197
We had experience of 464 cases of anesthesia for repair of cleft lip and cleft palate under 10 years of age. The analyzed results are as follows: 1) The 464 cases were divided into 5 age groups and 165 cases(35.6%) were in the under 2 years age group. Sex distribution was 291 males(66.2%) and 173 females(37.3%) 2) 377 cases(81.3%) were under 20kg of body weight. 3) There were 229 cleft lip cases (29.3%), 233 cleft palate cases, and 1 case each of (50.2%), of naso-ocular fistular correction and oro-ocular correction. 4) There were 386 cases elective surgery and 2 were emergency cases. 5) All cases had general anesthesia by means of endotracheal intubation 377 cases(81.3%) with a non-rebreathing system and 87 cases(18.8%) had a semi-closed absorption system. 6) The main anesthetic was halothane in 462 cases(99.6%) and Valium-Demerol and ether was 1 case each. 7) The mean blood loss in palatoplastry was 10ml/kg of body weight but it was 13.7ml/kg in the 5~10kg of body weight group, 11.6ml/kg in the 10kg~20kg of body weight group and 7.5ml/kg in the 20~30kg of body weight group. 8) Incidence of cleft lip combined with cleft palate was 211 cases(45.5%) among 464 cases and 149 cases(51.2%) were males and 62 cases(35.8%) were females. 9) The most common type of cleft lip was left incomplete lip(30.1%) and of cleft palate it was left complete palate(30.5%). 10) Familial history was found in 56 cases(12%).
Absorption
;
Anesthesia*
;
Anesthesia, General
;
Body Weight
;
Child*
;
Cleft Lip
;
Cleft Palate
;
Emergencies
;
Ether
;
Female
;
Halothane
;
Humans
;
Incidence
;
Intubation, Intratracheal
;
Male
;
Sex Distribution
2.Clinical Observation of Interscalene Brachial Plexus Block .
Yong Jo KIM ; Sook Ja KIM ; Byung Mu KIM ; Dong Ki LEE
Korean Journal of Anesthesiology 1981;14(2):180-184
We performed the interscalene technic of brachial plexus block for an operation of the upper extremity in 94 patients. We used 1%, 1.5% or 2% lidocaine solution with or without 1:200,000 epinephrine. There were paresthesias in all cases of needle puncture with the interscalene approach. The resutls were as follows: 1) Onset of anesthesia was observed in 3~10 minutes(average: 5 min.) 2) Complete anesthesia was observed in 10~30 minutes(average: 18 min.) 3) The mean interval of anesthesia to operation was 22 minutes. 4) We observed satisfactory blocks in 81 cases, unsatisfactory block in 8 cases and failure in 5 cases. 5) There were not any complications such as pneumothorax, dyspnea, convulsions, subarachnoid or epidural injection, etc.
Anesthesia
;
Brachial Plexus*
;
Dyspnea
;
Epinephrine
;
Humans
;
Injections, Epidural
;
Lidocaine
;
Needles
;
Paresthesia
;
Pneumothorax
;
Punctures
;
Seizures
;
Upper Extremity
3.A Case of Intracerebral Thrombosis and Cortical Hemorrhage Complicated by Streptococcus pneumoniae Meningitis.
Jin Youl CHO ; Byung Mu HAN ; Hwang Min KIM ; Baek Keun LIM ; Byung Ho CHA
Journal of the Korean Child Neurology Society 2003;11(2):362-366
Streptococcus pneumoniae is the most common pathogen of bacterial meningitis in childhood. It causes such intracranial complications as hydrocephalus, cerebral edema, inappropriate secretion of antidiuretic hormone(SIADH), and convulsion, and also such cerebral vascular complications as vasculitis, thrombosis, aneurysm, infarction, and subarachnoid hemorrhage. We report a male of 4 months old who had intracerebral cortical hemorrhage and sinovenous thrombosis complicated by streptococcus pneumoniae meningitis. Also, we reviewed the literature on intracerebral vascular complications related to bacterial meningitis.
Aneurysm
;
Brain Edema
;
Hemorrhage*
;
Humans
;
Hydrocephalus
;
Infant
;
Infarction
;
Male
;
Meningitis
;
Meningitis, Bacterial
;
Meningitis, Pneumococcal*
;
Seizures
;
Streptococcus pneumoniae*
;
Streptococcus*
;
Subarachnoid Hemorrhage
;
Thrombosis*
;
Vasculitis
4.Development of 166Ho-Stent for the Treatment of Esophageal Cancer.
Kyung Bae PARK ; Young Mi KIM ; Kyung Hwa KIM ; Byung Chul SHIN ; Woong Woo PARK ; Kwang Hee HAN ; Young Ju CHUNG ; Sang Mu CHOI ; Jong Doo LEE
Korean Journal of Nuclear Medicine 2000;34(1):62-73
PURPOSE: Esophageal cancer patients have a difficulty in the intake of meals through the blocked esophageal lumen, which is caused by an ingrowth of cancer cells and largely influences on the prognosis. It is reported that esophageal cancer has a very low survival rate due to the lack of nourishment and immunity as the result of this. In this study a new radioactive stent, which prevents tumor ingrowth and restenosis by additional radiation treatment, has been developed. MATERIALS AND METHODS: Using HANARO research reactor, the radioactive stent assembly (166Ho-SA) was prepared by covering the metallic stent with a radioactive sleeve by means of a post-irradiation and pre-irradiation methods. RESULTS: Scanning electron microscopy and autoradiography exhibited that the distribution of 165/166Ho (NO3) compounds in polyurethane matrix was homogeneous. A geometrical model of the esophagus considering its structural properties, was developed for the computer simulation of energy deposition to the esophageal wall. The dose distributions of 166Ho-stent were calculated by means of the EGS4 code system. The sources are considered to be distributed uniformly on the surface in the form of a cylinder with a diameter of 20 mm and length of 40 mm. As an animal experiment, when radioactive stent developed in this study was inserted into the esophagus of a Mongrel dog, tissue destruction and widening of the esophageal lumen were observed. CONCLUSION: We have developed a new radioactive stent comprising of a radioactive tubular sleeve covering the metallic stent, which emits homogeneous radiation. If it is inserted into the blocked or narrowed lumen, it can lead to local destruction of the tumor due to irradiation effect with dilatation resulting from self-expansion of the metallic property. Accordingly, it is expected that restenosis esophageal lumen by the continuous ingrowth and infiltration of cancer after insertion of our radioactive stent will be decreased remarkably.
Animal Experimentation
;
Animals
;
Autoradiography
;
Computer Simulation
;
Dilatation
;
Dogs
;
Esophageal Neoplasms*
;
Esophagus
;
Humans
;
Meals
;
Microscopy, Electron, Scanning
;
Polyurethanes
;
Prognosis
;
Stents
;
Survival Rate
5.Circadian Rhythm of Peak Expiratory Flow Rate in Asymptomatic Childhood Asthma.
Hwi Kyu IM ; Byung Mu HAN ; Seok Won PARK ; Jong Soo KIM
Pediatric Allergy and Respiratory Disease 2003;13(2):90-97
PURPOSE: Asthmatic patients show marked circadian variation in disease severity, with bronchospasm far worse between midnight and 8 a.m. than at other times of the day. And many studies have demonstrated that symptoms are much relieved in the day-time while they worsen at night. Our study was conducted to examine the circadian variation of peak expiratory flow rate (PEFR) in asymptomatic asthmatic children after proper treatment by mini-Wright peak flow meter. METHODS: Thirty four asthmatic patients who have had no respiratory symptoms for the past one month were enrolled to our study. Control group included 25 patients who were admitted to Wonju Christian Hospital for inguinal hernia, aseptic meningitis, etc., but without respiratory symptoms. RESULTS: The mean age was 6.3 years, ranging from 4 to 11 years, in the stable asthmatic group. In control group, the mean age was 8.7 years ranging from 4 to 14 years. PEFR was checked at every 2 hours from 8 a.m. to 10 p.m. for 4 days. There were no significant differences in PEFR checked at all times between the asthma group and the control group except for the PEFR checked at 8 a.m. in moderate persistent asthma group. PEFR reached the nadir at 8 a.m. in both asthma and control groups. It rose to the highest level in the afternoon, then, it slightly fell in the evening and at night. There were significant differences between the PEFR checked at 8 a.m. and the PEFR checked at any other period of the day in each group (P< 0.05). The circadian variation in moderate persistent asthma group is much greater than that of other groups. CONCLUSION: Our study indicates that the moderate persistent asthma group with no current symptoms of asthma has an increased circadian variability. It is recommended, therefore, that special attention be paid to preventive treatment for the moderate persistent asthma group.
Asthma*
;
Bronchial Spasm
;
Child
;
Circadian Rhythm*
;
Gangwon-do
;
Hernia, Inguinal
;
Humans
;
Meningitis, Aseptic
;
Peak Expiratory Flow Rate*
6.The Variations in Clinical Features According to Intoxicants in High Toxicity Organophosphorus Intoxication.
Mu Jin KIM ; Byung Kook LEE ; Kyung Woon JEUNG ; Hyun Ho RYU ; Jung Mi MOON
Journal of the Korean Society of Emergency Medicine 2009;20(4):392-398
PURPOSE: Organophosphorus (OP) pesticides are differentiated into 3 groups according to their toxicity. The differences in chemical composition of each OP pesticide determines its toxicokinetic characteristics. There are few human studies that address the clinical results of poisoning according to the OP pesticide. In this study, we aimed to examine the differences in clinical features among self-poisoning from 4 highly toxic OP pesticides. METHODS: The 4 kinds of OP poisonings included 17 cases of Dichlorvos, 17 cases of EPN, 17 cases of methidathion, and 13 cases of phosphamidon. We set primary outcomes as GCS, atropine dose required, duration of patient need for atropine, proportion who required ventilation, duration on ventilation, and the interval from ingestion to ventilation. Secondary outcomes were the proportion of OP-induced delayed neuropathy, duration of ICU stay, and proportion who required additional infusion of pralidoxime chloride (PAM). RESULTS: The EPN group required the largest amount of atropine, the longest duration of atropine use, the longest duration for support of mechanical ventilation, and the longest ICU stay. Furthermore the proportion who required additional PAM and neuropathy were in the EPN group. However, the EPN group had the longest interval from ingestion to ventilatory support. Meanwhile, the Dichlorvos group exhibited comparatively mild clinical features. CONCLUSION: Throughout this study, we found different clinical features to each OP pesticide poisoning. It can be explained by differences in chemical composition, which determined the speed of aging, the reactivation rate of OPenzyme, the metabolism, the fat solubility, and other characteristics of the pesticides.
Aging
;
Atropine
;
Dichlorvos
;
Eating
;
Humans
;
Organophosphorus Compounds
;
Organothiophosphorus Compounds
;
Pesticides
;
Phosphamidon
;
Pralidoxime Compounds
;
Respiration, Artificial
;
Solubility
;
Ventilation
7.Phloxine O, a Cosmetic Colorant, Suppresses the Expression of Thymic Stromal Lymphopoietin and Acute Dermatitis Symptoms in Mice.
Hye Eun LEE ; Gabsik YANG ; Kyu Bong KIM ; Byung Mu LEE ; Joo Young LEE
Biomolecules & Therapeutics 2018;26(5):481-486
Cosmetics are primarily applied to the skin; therefore, the association of cosmetic dyes with skin diseases or inflammation is a topic of great interest. Thymic stromal lymphopoietin (TSLP) is an interleukin 7-like cytokine that activates dendritic cells to promote Th2 inflammatory immune responses. TSLP is highly expressed in keratinocytes under inflammatory conditions, which suggests that it may play a critical role in the development of skin diseases, such as atopic dermatitis. Therefore, we investigated whether cosmetic dyes influenced the production of TSLP by keratinocytes. Phloxine O, also known as D&C Red No.27, is one of the most common red synthetic pigments and is widely used in colored cosmetics. Our results showed that Phloxine O downregulated phorbol 12-myristate 13-acetate-induced production of TSLP in a murine keratinocyte cell line (PAM212). Phloxine O also suppressed TSLP expression in KCMH-1 cells, which are mouse keratinocytes that constitutively produce high levels of TSLP. To investigate the in vivo effects of Phloxine O, we induced TSLP expression in mouse ear skin by topically applying MC903, a vitamin D3 analogue that is a well-known inducer of atopic dermatitis-like symptoms. Topical application of Phloxine O prevented MC903-induced TSLP production in mouse ear skin, attenuated the acute dermatitis-like symptoms and decreased serum IgE and histamine levels in mice. Suppression of TSLP expression by Phloxine O correlated with reduced expression of OX40 ligand and Th2 cytokines in mouse ear skin. Our results showed that Phloxine O may be beneficial to prevent dermatitis by suppressing the expression of TSLP and Th2 cytokines in skin.
Animals
;
Cell Line
;
Cholecalciferol
;
Coloring Agents
;
Cytokines
;
Dendritic Cells
;
Dermatitis*
;
Dermatitis, Atopic
;
Dilatation and Curettage
;
Ear
;
Female
;
Histamine
;
Immunoglobulin E
;
Inflammation
;
Interleukins
;
Keratinocytes
;
Mice*
;
OX40 Ligand
;
Skin
;
Skin Diseases
8.Effectiveness of the Cardiac Rehabilitation on Exercise Capacity and Risk Factor in Coronary Artery Obstructive Disease.
Chul KIM ; Jae Ki AHN ; In Keol BANG ; Kun Joo RHEE ; Byung Ok KIM ; Mu Cheol SO ; Young Joo KIM ; In Tak JUNG
Journal of the Korean Academy of Rehabilitation Medicine 2006;30(1):74-79
OBJECTIVE: To evaluate the effectiveness of cardiac rehabilitation (CR) program on the exercise capacity and secondary prevention in coronary artery obstructive disease (CAOD). METHOD: CR group of 48 CAOD patients had underwent regularly supervised exercise training for 6~8 weeks as well as home exercise continued for 1 year. CR group was advised to control their risk factors by nutrition counsel, abstaining from smoking and reducing their weight. Control group of 16 CAOD patients did not participate in the CR program. Two groups were evaluated for their exercise capacity and risk factors at baseline and after 1 year. RESULTS: CR group showed significantly higher maximal oxygen consumption, maximal rate pressure product and ratings of perceived exertion at stage 3 compared with control group (p<0.05). The number of risk factors per person after 1 year in both groups was significantly lower than baseline (p<0.05), but there was no significant difference between the two groups. CONCLUSION: CR program can improve the exercise capacity and level of risk factor in CAOD patients. Therefore, CR program is recommended for helping CAOD patients improve their functional capacity and reduce the possibility of recurrence.
Coronary Vessels*
;
Humans
;
Oxygen Consumption
;
Recurrence
;
Rehabilitation*
;
Risk Factors*
;
Secondary Prevention
;
Smoke
;
Smoking
9.A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1.
Umasankar DE ; Soma KUNDU ; Nabanita PATRA ; Mee Young AHN ; Ji Hae AHN ; Ji Yeon SON ; Jung Hyun YOON ; Hyung Ryoung MOON ; Byung Mu LEE ; Hyung Sik KIM
Biomolecules & Therapeutics 2015;23(5):434-441
Histone deacetylase (HDAC) inhibitors are considered novel agents for cancer chemotherapy. We previously investigated MHY219, a new HDAC inhibitor, and its potent anticancer activity in human prostate cancer cells. In the present study, we evaluated MHY219 molecular mechanisms involved in the regulation of prostate cancer cell migration. Similar to suberanilohydroxamic acid (SAHA), MHY219 inhibited HDAC1 enzyme activity in a dose-dependent manner. MHY219 cytotoxicity was higher in LNCaP (IC50=0.67 muM) than in DU145 cells (IC50=1.10 muM) and PC3 cells (IC50=5.60 muM) after 48 h of treatment. MHY219 significantly inhibited the HDAC1 protein levels in LNCaP and DU145 cells at high concentrations. However, inhibitory effects of MHY219 on HDAC proteins levels varied based on the cell type. MHY219 significantly inhibited LNCaP and DU145 cells migration by down-regulation of matrix metalloprotease-1 (MMP-1) and MMP-2 and induction of tissue inhibitor of metalloproteinases-1 (TIMP-1). These results suggest that MHY219 may potentially be used as an anticancer agent to block cancer cell migration through the repression of MMP-1 and MMP-2, which is related to the reduction of HDAC1.
Cell Movement
;
Down-Regulation
;
Drug Therapy
;
Histone Deacetylase Inhibitors*
;
Histone Deacetylases*
;
Histones*
;
Humans*
;
Matrix Metalloproteinases
;
Prostate*
;
Prostatic Neoplasms*
;
Repression, Psychology
10.Relationship between CD44v6 Expression and Clinicopathologic Parameters in Endometrial Carcinomas.
Byung Sub SHIN ; Jae Heok JEONG ; En Ju JEONG ; Mu Sung JOO ; Seung Seop PARK ; Ki Hyung KIM ; Man Soo YOON
Korean Journal of Obstetrics and Gynecology 2004;47(9):1690-1697
OBJECTIVE: The purpose of this study was to evaluate the clinical usefulness of CD44v6 in patients with histologically confirmed endometrial cancer. METHODS: Immunohistochemistry was used to determine the expression of CD44v6 in 39 hysterectomy specimens with the diagnosis of endometrial cancer. RESULTS: CD44v6 expression was detected in 8 specimens with no myometrial invasion of endometrial cancer, one specimen with <50% myometrial invasion, and none with >50% myometrial invasion. There was a significant association between CD44v6 expression and no myometrial invasion of endometrial cancer. There was a statistically significant association between CD44v6 expression and lymph node metastasis, lymphovascular involvement. And all cases of CD44v6 expression were FIGO stage I with histological grade 1 or 2. CD44v6 expression was statistically related with estrogen receptor expression. Although statistical significance was not revealed, it was likely that CD44v6 expression was related with progesterone receptor expression with positive predictive value of 6/9 (66.7%). CONCLUSION: Significant relationships between myometrial invasion, lymph node metastasis, lymphovascular involvement, surgical stage and expression of estrogen receptor and CD44v6 expression suggest that CD44v6 expression could be a good prognostic factor. CD44v6 expression may have potential clinical usefulness if this expression is demonstrated in a further study with prehysterectomy sampling specimens containing endometrial cancer.
Diagnosis
;
Endometrial Neoplasms*
;
Estrogens
;
Female
;
Humans
;
Hysterectomy
;
Immunohistochemistry
;
Lymph Nodes
;
Neoplasm Metastasis
;
Receptors, Progesterone